dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Conteduca, Vincenza |
dc.contributor.author | Jayaram, Anuradha |
dc.contributor.author | Romero-Laorden, Nuria |
dc.contributor.author | Wetterskog, Daniel |
dc.contributor.author | Salvi, Samanta |
dc.contributor.author | Gurioli, Giorgia |
dc.contributor.author | Morales Barrera, Rafael |
dc.date.accessioned | 2021-03-18T08:46:10Z |
dc.date.available | 2021-03-18T08:46:10Z |
dc.date.issued | 2019-03 |
dc.identifier.citation | Conteduca V, Jayaram A, Romero-Laorden N, Wetterskog D, Salvi S, Gurioli G, et al. Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2019 Mar;75(3):368–73. |
dc.identifier.issn | 0302-2838 |
dc.identifier.uri | https://hdl.handle.net/11351/5769 |
dc.description | Cáncer de próstata; Receptor de andrógenos; Docetaxel |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | European Urology;75(3) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pròstata - Càncer |
dc.subject | Metàstasi |
dc.subject | Antiandrògens |
dc.subject.mesh | Prostatic Neoplasms, Castration-Resistant |
dc.subject.mesh | Androgen Receptor Antagonists |
dc.subject.mesh | Docetaxel |
dc.title | Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.eururo.2018.09.049 |
dc.subject.decs | neoplasias prostáticas resistentes a la castración |
dc.subject.decs | antagonistas de andrógenos |
dc.subject.decs | docetaxel |
dc.relation.publishversion | https://www.europeanurology.com/article/S0302-2838(18)30739-5/fulltext |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Conteduca V] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. [Jayaram A] Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. The Royal Marsden NHS Foundation Trust, London, UK. University College London Cancer Institute, London, UK. [Romero-Laorden N] Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain. Hospital Universitario La Princesa, Madrid, Spain. [Wetterskog D] Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. University College London Cancer Institute, London, UK. [Salvi S, Gurioli G] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. [Morales R] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 30773204 |
dc.identifier.wos | 000458490100019 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/PI16%2F01565 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F01499 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI15%2F676 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |